Iridex Corporation

Iridex Corporation is a medical technology company established in 1989, specializing in laser-based medical systems and devices for ophthalmology and select ENT applications. Headquartered in Mountain View, California, Iridex is recognized as a global leader in ophthalmic laser technology. The company offers a comprehensive portfolio of laser systems, delivery devices, retinal surgical instruments, consumables, and glaucoma devices. Flagship products include the PASCAL® laser system with patented MicroPulse™ technology, Cyclo G6, OcuLight, IQ 532, IQ 577, G-Probe systems, and MicroPulse P3 devices for transscleral cyclophotocoagulation. Iridex's MicroPulse® technology enables safer, tissue-sparing treatments for retinal diseases including diabetic macular edema, age-related macular degeneration, and central serous chorioretinopathy, as well as non-incisional glaucoma management. The company distributes directly in the U.S. through a sales force and via approximately 60 independent distributors across over 100 countries. Iridex provides extensive physician education, clinical support, training, and humanitarian initiatives.